TABLE 4.
Soluble Protein Analysis
| H | ES | LT | P | |
|---|---|---|---|---|
| EPO (pg/mL) | 2.8 ± 1.8 | 3.0 ± 2 | 5.1 ± 4.2† | 0.004** |
| CRP (pg/mL) | 13.8 ± 13 | 77 ± 90 ¶ | 42 ± 83 | 0.109 |
| ICAM1 (pg/mL) | 1.4 ± 0.5 | 2.7 ± 1.8¶ | 1.6 ± 0.1 # | 0.382 |
| VCAM1 (pg/mL) | 2.43 ± 0.9 | 3.58 ± 2.01 | 3.22 ± 1.31 | 0.071 |
P < 0.05,
P < 0.01 H indicates healthy; ES, early stage diabetes; LT, long term diabetes. Post-hoc comparison significance levels (not adjusted for multiple comparisons)
P < 0.01 LT vs. H,
P <0.01 ES vs. H,
P < 0.01 LT vs. ES.
P< 0.05 LT vs. H,
P < 0.05 ES vs. H,
P < 0.05 LT vs. ES
P calculated by JT test to test for differences between the three groups. Post-hoc analyses between patient groups used the two sample Wilcoxon test.